Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 30, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

What is the patent landscape for Zoledronic Acid, and when can generic versions of Zoledronic Acid launch?

Zoledronic Acid is a drug marketed by Emcure Pharms Ltd, Fresenius Kabi Usa, Hospira Inc, Gland Pharma Ltd, Akorn, Sun Pharma Global, Usv North America, Acs Dobfar Info Sa, Mylan Labs Ltd, Akorn Inc, Aurobindo Pharma Ltd, Dr Reddys Labs Ltd, Pharmaceutics, Apotex Inc, Pharms, Actavis Inc, Accord Hlthcare, Hikma Farmaceutica, and Sagent Pharms. and is included in twenty-eight NDAs.

The generic ingredient in ZOLEDRONIC ACID is zoledronic acid. There are twenty-five drug master file entries for this compound. Nineteen suppliers are listed for this compound. There are twelve tentative approvals for this compound. Additional details are available on the zoledronic acid profile page.

Summary for Tradename: ZOLEDRONIC ACID

Suppliers / Packagers: see list18
Bulk Api Vendors: see list86
Clinical Trials: see list2,082
Patent Applications: see list2,770
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ZOLEDRONIC ACID at DailyMed

Pharmacology for Tradename: ZOLEDRONIC ACID

Drug ClassBisphosphonate
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sagent Pharms
zoledronic acid
INJECTABLE;IV (INFUSION)091493-001Nov 24, 2014APRXNoNo► Subscribe► Subscribe
Emcure Pharms Ltd
zoledronic acid
INJECTABLE;IV (INFUSION)201801-001Mar 29, 2013APRXNoNo► Subscribe► Subscribe
Dr Reddys Labs Ltd
zoledronic acid
INJECTABLE;IV (INFUSION)091363-001Mar 29, 2013APRXNoNo► Subscribe► Subscribe
Accord Hlthcare
zoledronic acid
INJECTABLE;IV (INFUSION)205279-001Nov 28, 2016APRXNoNo► Subscribe► Subscribe
Hospira Inc
zoledronic acid
INJECTABLE;IV (INFUSION)090621-001Mar 19, 2015APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Predict branded drug patent expiration
  • Formulary management
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus